news
Novel treatments emerging for human mitochondrial diseases
20 July 2015 | By
Using existing drugs to restore basic biological processes in human cells, researchers may have devised effective treatments for mitochondrial diseases...
List view / Grid view
Diabetes
news
Genetic markers linking risk for type 2 diabetes and Alzheimer’s identified
20 July 2015 | By Victoria White
Certain patients with type 2 diabetes may have specific genetic risk factors that put them at higher risk for developing Alzheimer’s disease...
news
First European nanomedicine characterisation laboratory launches
1 July 2015 | By Victoria White
A European Nano-Characterisation Laboratory has launched with the aim of reaching a level of international excellence in nanomedicine characterisation...
news
Smart insulin patch could make painful injections a thing of the past for diabetes sufferers
23 June 2015 | By Victoria White
Researchers have created the first smart insulin patch that can detect increases in blood sugar levels and secrete doses of insulin into the bloodstream...
news
New tool identifies potential anti-diabetes compound, azoramide
18 June 2015 | By Victoria White
A new drug screening technology developed at the Harvard T.H. Chan School of Public Health has identified a new potential anti-diabetes compound - azoramide...
news
AstraZeneca and Inserm collaborate to investigate new therapeutic approaches to diabetes and CKD
17 June 2015 | By Victoria White
AstraZeneca is to collaborate with Inserm to investigate new therapeutic approaches to type 2 diabetes and Chronic Kidney Disease (CKD)...
news
Understanding regulation of urocortin 3 could lead to new diabetes treatments
16 June 2015 | By Victoria White
Researchers have found that a hormone called urocortin 3 is released at the same time as insulin and acts to damp down insulin production...
news
New compound that represses the PPARy protein could be potential treatment for osteoporosis
12 June 2015 | By Victoria White
Researchers combined a variety of structural biology approaches to rationally design a new compound that could repress the biological activity of PPARy...
news
Astellas and Anokion establish Kanyos Bio to develop products for type 1 diabetes and coeliac disease
2 June 2015 | By Victoria White
Astellas Pharma and Anokion are to collaborate in the fields of type 1 diabetes and coeliac disease by establishing new drug discovery company Kanyos Bio...
news
TSRI scientists win $2.2 million to expand study of IP6K1 to help develop new obesity therapies
28 May 2015 | By Victoria White
TSRI scientists have been awarded nearly $2.2 million to advance understanding of IP6K1 and develop innovative approaches for the treatment of obesity...
news
Zealand starts clinical development of a multiple-dose version of ZP4207
20 May 2015 | By Victoria White
Zealand has advanced a multiple-dose version of ZP4207 into clinical development for the treatment of mild to moderate hypoglycaemia in diabetes patients...
news
Genetic mutation could protect against development of Type 2 diabetes
29 April 2015 | By Victoria White
An international team of scientists has identified a new genetic mutation that appears to protect people from developing Type 2 diabetes...
news
CiRA and Takeda to collaborate on iPS Cell Research
17 April 2015 | By Victoria White
Takeda and CiRA to work together to develop clinical applications of induced pluripotent stem cells in areas such as diabetes mellitus and immunotherapy...
news
AstraZeneca and PatientsLikeMe announce global research collaboration
13 April 2015 | By Victoria White
AstraZeneca and PatientsLikeMe have signed an agreement to provide AZ with access to PatientsLikeMe’s global network to shape future medicine development...
news
Pfizer appoints Dr Charles Reay Mackay as Chief Scientific Officer, Inflammation and Immunology Research Unit
31 March 2015 | By Victoria White
Pfizer Inc. has announced that Charles Reay Mackay will join the company as Chief Scientific Officer for Pfizer’s Inflammation and Immunology Research Unit...